Nasus Pharma Ltd. (NSRX)

NYSEAMERICAN: NSRX · Real-Time Price · USD

2.350

-0.200 (-7.84%)

At close: Apr 2, 2026, 4:00 PM EDT

2.340

-0.010 (-0.41%)

After-hours: Apr 2, 2026, 8:00 PM EDT

Nasus Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	28	83	-	-	-
Enterprise Value	23	85	-	-	-
Last Close Price	2.35	9.15	-	-	-
PB Ratio	7.65	29.95	-	-	-
P/TBV Ratio	9.94	29.95	-	-	-
Debt / Equity Ratio	0.04	0.04	-0.56	-0.65	-0.56
Net Debt / Equity Ratio	-1.51	-1.51	-0.47	-0.60	-0.51
Net Debt / FCF Ratio	0.85	0.85	-2.28	-2.20	-1.17
Quick Ratio	1.98	1.98	0.07	0.05	0.05
Current Ratio	2.25	2.25	0.12	0.11	0.13
Return on Assets (ROA)	-107.15%	-107.15%	-116.06%	-166.52%	-
Return on Capital Employed (ROCE)	-172.60%	-172.60%	33.60%	30.20%	73.30%
Earnings Yield	-21.28%	-7.06%	-	-	-
FCF Yield	-17.92%	-5.95%	-	-	-
Buyback Yield / Dilution	-15.11%	-13.98%	0.43%	-2.44%	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q